| Semin Neurol. 2004 Mar;24(1):41-8. |
|
Management of myasthenia gravis.
Saperstein DS, Barohn RJ.
Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
Although once a severe and often fatal illness, myasthenia gravis can now be well managed with several relatively safe and effective therapies. Management involves a graded approach, beginning with cholinesterase inhibitors for mild symptoms and advancing to immunomodulating medications for more severe weakness. There are several immunomodulating agents from which to choose; selection is based largely on time to clinical effect and adverse effects. This review will discuss the selection and use of therapies for patients with myasthenia gravis.
Publication Types:
PMID: 15229791 [PubMed - indexed for MEDLINE]
|
